Morpholine, 4-[[6-chloro-4-(1-methylethyl)-3-pyridinyl]carbonyl]-(676626-82-7)
- Name: Morpholine, 4-[[6-chloro-4-(1-methylethyl)-3-pyridinyl]carbonyl]-
- Synonyms:
- Molecular Formula:C13H17ClN2O2
- Molecular Weight:
- CAS Registry Number:676626-82-7
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 676626-48-5/Butanoic acid, 3-(acetylamino)-4-[[3-[[(2S)-2-(acetylamino)-6-amino-1-oxohexyl]amino] -2-[[[(2S)-2-(acetylamino)-3-hydroxy-1-oxopropyl]amino]methyl]-2-[[[(2S) -2-(acetylamino)-3-(4-hydroxyphenyl)-1-oxopropyl]amino]methyl]propyl] amino]-4-oxo-, (3S)-
- 676626-58-7/2,5,9,12-Tetraazatridecanedioic acid, 7-(azidomethyl)-3-(carboxymethyl)-4,10-dioxo-11-(phenylmethyl)-7-[[[(2- propenyloxy)carbonyl]amino]methyl]-, 1,13-bis(9H-fluoren-9-ylmethyl) ester, (3S,11S)-
- 676626-59-8/2,5,9,12-Tetraazatridecanedioic acid, 7,7-bis(azidomethyl)-3,11-bis(carboxymethyl)-4,10-dioxo-, 1,13-bis(9H-fluoren-9-ylmethyl) ester, (3S,11S)-
- 676626-60-1/11-Oxa-2,5,9-triazatetradec-13-enoic acid, 7-[(acetylamino)methyl]-7-(azidomethyl)-4,10-dioxo-3-(phenylmethyl)-, 9H-fluoren-9-ylmethyl ester, (3S)-
- 676626-61-2/2,5,9,12-Tetraazatridecanedioic acid, 7-(azidomethyl)-3,11-bis(carboxymethyl)-4,10-dioxo-7-[[[(2-propenyloxy )carbonyl]amino]methyl]-, 1,13-bis(9H-fluoren-9-ylmethyl) ester, (3S,11S)-
- 676626-64-5/3-Pyridinecarboxylic acid, 6-[(3-chlorophenyl)amino]-4-(trifluoromethyl)-, methyl ester
- 676626-65-6/Glycine, N-[4-[4-[[[3-amino-2,2-bis(azidomethyl)propyl]amino]methyl]-3,5-dimeth oxyphenoxy]-1-oxobutyl]-L-leucyl-L-phenylalanyl-
- 676626-66-7/3-Pyridinecarboxylic acid, 6-[(3-chlorophenyl)amino]-4-(trifluoromethyl)-, monohydrochloride
- 676626-67-8/Glycine, N-[4-[4-[[[3-amino-2-(azidomethyl)-2-[[[(2-propenyloxy)carbonyl]amino] methyl]propyl]amino]methyl]-3,5-dimethoxyphenoxy]-1-oxobutyl]-L-leucyl- L-phenylalanyl-
- 676626-68-9/3-Pyridinecarboxamide, 6-chloro-N-(cyclohexylmethyl)-4-(1-methylethyl)-
- 676626-70-3/3-Pyridinecarboxamide, 6-chloro-N-(cyclobutylmethyl)-4-(1-methylethyl)-
- 676626-72-5/2,5,9,12-Tetraazatridecanedioic acid, 7,7-bis(azidomethyl)-3-(2-carboxyethyl)-11-(carboxymethyl)-4,10-dioxo- , 1,13-bis(9H-fluoren-9-ylmethyl) ester, (3S,11S)-
- 676626-73-6/3-Pyridinecarboxamide, 6-chloro-N-[(tetrahydro-2H-pyran-4-yl)methyl]-
- 676626-74-7/2,5,9,12-Tetraazatridecanedioic acid, 7,7-bis(azidomethyl)-3-(carboxymethyl)-4,10-dioxo-11-(phenylmethyl)-, 1,13-bis(9H-fluoren-9-ylmethyl) ester, (3S,11S)-
- 676626-75-8/Glycine, N-[4-(4-formyl-3-methoxyphenoxy)-1-oxobutyl]-L-leucyl-L-phenylalanyl-
- 676626-76-9/3-Pyridinecarboxamide, 6-chloro-4-(1-methylethyl)-N-[(tetrahydro-2H-pyran-4-yl)methyl]-
- 676626-77-0/Glycine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-phenylalanyl-5-[4-[[[3-amino-2,2- bis(azidomethyl)propyl]amino]methyl]phenoxy]pentanoyl-L-leucyl-L-phen ylalanyl-
- 676626-78-1/3-Pyridinecarboxamide, 6-chloro-N-(cyclopentylmethyl)-
- 676626-81-6/3-Pyridinecarboxamide, 6-chloro-N-(cyclopentylmethyl)-4-(1-methylethyl)-
- 676626-82-7/Morpholine, 4-[[6-chloro-4-(1-methylethyl)-3-pyridinyl]carbonyl]-
- 676626-84-9/3-Pyridinecarboxylic acid, 6-chloro-4-(1-methylethyl)-
- 676626-86-1/3-Pyridinecarboxylic acid, 6-[(3-chlorophenyl)amino]-4-(1-methylethyl)-
- 676626-87-2/3-Pyridinecarboxamide, 6-chloro-N-(cyclohexylmethyl)-4-(1,1-dimethylethyl)-
- 676626-88-3/3-Pyridinecarboxamide, 6-chloro-4-(1,1-dimethylethyl)-N-[(tetrahydro-2H-pyran-4-yl)methyl]-
- 676626-90-7/3-Pyridinecarboxylic acid, 6-[(2,3-dichlorophenyl)amino]-4-(trifluoromethyl)-, methyl ester
- 676626-91-8/5(4H)-Oxazolone, 4-[(3,4-dimethylphenyl)methylene]-2-methyl-, (4Z)-
- 676626-92-9/3-Pyridinecarboxylic acid, 6-[(2,3-dichlorophenyl)amino]-4-(trifluoromethyl)-
- 676626-93-0/2-Propenoic acid, 3-(3,4-dimethylphenyl)-2-hydroxy-, (2Z)-
- 676626-94-1/3-Pyridinecarboxylic acid, 6-[(2,4-dichlorophenyl)amino]-4-(trifluoromethyl)-, methyl ester
- 676626-96-3/3-Pyridinecarboxylic acid, 6-[(2,4-dichlorophenyl)amino]-4-(trifluoromethyl)-